Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Clinical Trials, High Risk Prostate Cancer

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05384535
Phase: Not Applicable
Trial Summary: To determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protoc – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Northwell Health
Acronym:

Pin It on Pinterest